» Articles » PMID: 24496106

Screening and Discovery of Nitro-benzoxadiazole Compounds Activating Epidermal Growth Factor Receptor (EGFR) in Cancer Cells

Abstract

Peptide ligand-induced dimerization of the extracellular region of the epidermal growth factor receptor (sEGFR) is central to the signal transduction of many cellular processes. A small molecule microarray screen has been developed to search for non-peptide compounds able to bind to sEGFR. We describe the discovery of nitro-benzoxadiazole (NBD) compounds that enhance tyrosine phosphorylation of EGFR and thereby trigger downstream signaling pathways and other receptor tyrosine kinases in cancer cells. The protein phosphorylation profile in cells exposed to NBD compounds is to some extent reminiscent of the profile induced by the cognate ligand. Experimental studies indicate that the small compounds bind to the dimerization domain of sEGFR, and generate stable dimers providing allosteric activation of the receptor. Moreover, receptor phosphorylation is associated with inhibition of PTP-1B phosphatase. Our data offer a promising paradigm for investigating new aspects of signal transduction mediated by EGFR in cancer cells exposed to electrophilic NBD compounds.

Citing Articles

Targeted Strategies for Degradation of Key Transmembrane Proteins in Cancer.

Sakanyan V, Iradyan N, Alves de Sousa R BioTech (Basel). 2023; 12(3).

PMID: 37754201 PMC: 10526213. DOI: 10.3390/biotech12030057.


In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice.

Bhat Z, Kumar M, Sharma N, Yadav U, Singh T, Joshi G Molecules. 2022; 27(17).

PMID: 36080307 PMC: 9457798. DOI: 10.3390/molecules27175540.


Compounds with capacity to quench the tyrosyl radical in Pseudomonas aeruginosa ribonucleotide reductase.

Berggren G, Sahlin M, Crona M, Tholander F, Sjoberg B J Biol Inorg Chem. 2019; 24(6):841-848.

PMID: 31218442 PMC: 6754346. DOI: 10.1007/s00775-019-01679-w.


Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice.

Singh A, Mia M, Cibi D, Arya A, Bhadada S, Singh M J Biol Chem. 2019; 294(21):8336-8347.

PMID: 30979723 PMC: 6544867. DOI: 10.1074/jbc.RA118.007063.


Reactive Chemicals and Electrophilic Stress in Cancer: A Minireview.

Sakanyan V High Throughput. 2018; 7(2).

PMID: 29702613 PMC: 6023294. DOI: 10.3390/ht7020012.


References
1.
Yun C, Mengwasser K, Toms A, Woo M, Greulich H, Wong K . The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci U S A. 2008; 105(6):2070-5. PMC: 2538882. DOI: 10.1073/pnas.0709662105. View

2.
Weidner K, Di Cesare S, Sachs M, Brinkmann V, Behrens J, Birchmeier W . Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature. 1996; 384(6605):173-6. DOI: 10.1038/384173a0. View

3.
Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim J . Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 2002; 110(6):775-87. DOI: 10.1016/s0092-8674(02)00963-7. View

4.
Liu F, Chernoff J . Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. Biochem J. 1997; 327 ( Pt 1):139-45. PMC: 1218773. DOI: 10.1042/bj3270139. View

5.
Wilson K, Gilmore J, Foley J, Lemmon M, Riese 2nd D . Functional selectivity of EGF family peptide growth factors: implications for cancer. Pharmacol Ther. 2009; 122(1):1-8. PMC: 2665203. DOI: 10.1016/j.pharmthera.2008.11.008. View